Overview Dividends

(CCLD) CareCloud - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14167R1005

Cloud Medical, Practice Management, Billing Software, Analytics

CCLD EPS (Earnings per Share)

EPS Growth (3Y CAGR): 28.88%
EPS Trend (3Y Correlation): 75.9%

CCLD Revenue

Revenue Growth (3Y CAGR): -7.30%
Revenue Trend (3Y Correlation): -79.1%

Risk via 10d forecast
Volatility	93.1%
Value at Risk 5%th	124%
Relative Tail Risk	-19.19%

Reward TTM
Sharpe Ratio	0.64
Alpha	-19.30

Character TTM
Hurst Exponent	0.380
Beta	1.421
Beta Downside	1.518

Drawdowns 3y
Max DD	82.54%
Mean DD	42.92%
Median DD	41.90%

Description: CCLD CareCloud August 21, 2025

CareCloud Inc. (NASDAQ:CCLD) is a US-based company operating in the Health Care Equipment sub-industry. To understand its financial health, we need to examine its income statement, particularly the yearly Income Tax Expense. A thorough analysis of this component can reveal the companys tax strategy and its impact on profitability.

From a fundamental perspective, CareClouds market capitalization stands at $110.04 million, indicating a relatively small-cap stock. The forward Price-to-Earnings ratio is 8.97, suggesting that investors have certain expectations for the companys future earnings growth. Return on Equity (RoE) is 21.82%, which is a positive indicator of the companys ability to generate profits from shareholders equity.

To further assess CareClouds performance, key economic drivers such as revenue growth, operating margins, and cash flow generation should be examined. Important KPIs to monitor include the companys ability to maintain a healthy balance between revenue expansion and expense management, as well as its capacity to invest in research and development to drive future growth. Additionally, metrics like Days Sales Outstanding (DSO) and the Current Ratio can provide insights into the companys working capital management and liquidity position.

From an investment perspective, its crucial to evaluate CareClouds competitive positioning within the healthcare technology sector, its customer base, and the overall demand for its products or services. An analysis of the companys management team, their track record, and the effectiveness of their strategic initiatives can also provide valuable insights into potential future performance.

CCLD Stock Overview

Market Cap in USD	125m
Sub-Industry	Health Care Equipment
IPO / Inception	2014-07-23
Return 12m vs S&P 500	6.67%
Analyst Rating	3.50 of 5

CCLD Dividends

Currently no dividends paid

CCLD Growth Ratios

CAGR 3y	1.32%
CAGR/Max DD Calmar Ratio	0.02
CAGR/Mean DD Pain Ratio	0.03
Current Volume	516.8k
Average Volume	334.3k

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (11.3m TTM) > 0 and > 6% of Revenue (6% = 6.71m TTM)

FCFTA 0.29 (>2.0%) and ΔFCFTA 15.99pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 13.28% (prev 0.60%; Δ 12.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.33 (>3.0%) and CFO 24.8m > Net Income 11.3m (YES >=105%, WARN >=100%)

Net Debt (-7.05m) to EBITDA (25.2m) ratio: -0.28 <= 3.0 (WARN <= 3.5)

Current Ratio 1.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (33.1m) change vs 12m ago 105.3% (target <= -2.0% for YES)

Gross Margin 42.98% (prev 41.25%; Δ 1.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 149.8% (prev 151.0%; Δ -1.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 30.69 (EBITDA TTM 25.2m / Interest Expense TTM 373.0k) >= 6 (WARN >= 3)

Altman Z'' -3.96

(A) 0.20 = (Total Current Assets 31.1m - Total Current Liabilities 16.2m) / Total Assets 75.2m

(B) -0.82 = Retained Earnings (Balance) -61.8m / Total Assets 75.2m

(D) -3.44 = Book Value of Equity -65.9m / Total Liabilities 19.2m

Total Rating: -3.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.05

1. Piotroski 7.0pt = 2.0

2. FCF Yield 18.47% = 5.0

3. FCF Margin 19.46% = 4.87

4. Debt/Equity 0.06 = 2.50

5. Debt/Ebitda -0.28 = 2.50

6. ROIC - WACC (= 10.71)% = 12.50

7. RoE 21.82% = 1.82

8. Rev. Trend -79.10% = -5.93

9. EPS Trend 75.92% = 3.80

What is the price of CCLD shares?

As of November 15, 2025, the stock is trading at USD 3.13 with a total of 516,775 shares traded.
Over the past week, the price has changed by -9.67%, over one month by -3.10%, over three months by +22.27% and over the past year by +22.27%.

Is CareCloud a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, CareCloud (NASDAQ:CCLD) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.05 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCLD is around 2.72 USD . This means that CCLD is currently overvalued and has a potential downside of -13.1%.

Is CCLD a buy, sell or hold?

CareCloud has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold CCLD.

Strong Buy: 0
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CCLD price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	4.8	51.8%
Analysts Target Price	4.8	51.8%
ValueRay Target Price	3.1	-1%

CCLD Fundamental Data Overview November 02, 2025

Market Cap USD = 124.8m (124.8m USD * 1.0 USD.USD)
P/E Forward = 9.0992
P/S = 1.1168
P/B = 2.5058
Beta = 2.108
Revenue TTM = 111.8m USD
EBIT TTM = 11.4m USD
EBITDA TTM = 25.2m USD
Long Term Debt = 86.0k USD (from longTermDebt, last quarter)
Short Term Debt = 1.52m USD (from shortTermDebt, last quarter)
Debt = 3.39m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -7.05m USD (from netDebt column, last quarter)
Enterprise Value = 117.8m USD (124.8m + Debt 3.39m - CCE 10.4m)
Interest Coverage Ratio = 30.69 (Ebit TTM 11.4m / Interest Expense TTM 373.0k)
FCF Yield = 18.47% (FCF TTM 21.8m / Enterprise Value 117.8m)
FCF Margin = 19.46% (FCF TTM 21.8m / Revenue TTM 111.8m)
Net Margin = 10.08% (Net Income TTM 11.3m / Revenue TTM 111.8m)
Gross Margin = 42.98% ((Revenue TTM 111.8m - Cost of Revenue TTM 63.7m) / Revenue TTM)
Gross Margin QoQ = 34.76% (prev 44.04%)
Tobins Q-Ratio = 1.57 (Enterprise Value 117.8m / Total Assets 75.2m)
Interest Expense / Debt = 2.01% (Interest Expense 68.0k / Debt 3.39m)
Taxrate = 1.43% (42.0k / 2.94m)
NOPAT = 11.3m (EBIT 11.4m * (1 - 1.43%))
Current Ratio = 1.91 (Total Current Assets 31.1m / Total Current Liabilities 16.2m)
Debt / Equity = 0.06 (Debt 3.39m / totalStockholderEquity, last quarter 56.1m)
Debt / EBITDA = -0.28 (Net Debt -7.05m / EBITDA 25.2m)
Debt / FCF = -0.32 (Net Debt -7.05m / FCF TTM 21.8m)
Total Stockholder Equity = 51.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.98% (Net Income 11.3m / Total Assets 75.2m)
RoE = 21.82% (Net Income TTM 11.3m / Total Stockholder Equity 51.6m)
RoCE = 22.13% (EBIT 11.4m / Capital Employed (Equity 51.6m + L.T.Debt 86.0k))
RoIC = 21.72% (NOPAT 11.3m / Invested Capital 52.0m)
WACC = 11.01% (E(124.8m)/V(128.2m) * Re(11.25%) + D(3.39m)/V(128.2m) * Rd(2.01%) * (1-Tc(0.01)))
Discount Rate = 11.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 3.28%
[DCF Debug] Terminal Value 71.73% ; FCFE base≈16.9m ; Y1≈20.8m ; Y5≈35.5m
Fair Price DCF = 8.58 (DCF Value 363.0m / Shares Outstanding 42.3m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 75.92 | EPS CAGR: 28.88% | SUE: -0.28 | # QB: 0
Revenue Correlation: -79.10 | Revenue CAGR: -7.30% | SUE: 0.14 | # QB: 0

Additional Sources for CCLD Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle